Neurophet SCALE PET

by Neurophet., Inc. — Automated quantification of brain PET images for neurodegenerative disease assessment.
Neurology Nuclear Medicine Radiology

Enterprise
Regulatory Status Disclosed

Overview

Neurophet SCALE PET is an AI-powered medical device designed to provide quantitative analysis of brain PET images. It assists physicians in the diagnosis and management of neurodegenerative diseases, particularly Alzheimer’s disease. The tool automatically segments brain regions and quantifies amyloid and tau PET ligand uptake, offering objective biomarkers to support clinical decision-making.

The software processes PET images to generate standardized uptake value ratio (SUVR) maps and provides region-of-interest (ROI) based quantification. This allows clinicians to compare patient scans against normative databases, aiding in the early detection and differential diagnosis of various dementias. By automating these complex analyses, Neurophet SCALE PET aims to reduce inter-reader variability and improve the efficiency of image interpretation.

Neurophet SCALE PET is intended for use by qualified medical professionals in clinical settings. Its quantitative output can be integrated into patient reports, providing valuable insights for treatment planning, monitoring disease progression, and assessing response to therapy. The tool is designed to enhance the diagnostic workflow in neurology and nuclear medicine departments.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated brain PET image segmentation
  • Quantification of amyloid PET ligand uptake
  • Quantification of tau PET ligand uptake
  • Standardized Uptake Value Ratio (SUVR) maps
  • Region-of-interest (ROI) analysis
  • Comparison with normative databases
  • Support for Alzheimer's disease diagnosis
  • Aid in differential diagnosis of dementias

Use Cases

  • Diagnosis of Alzheimer's disease
  • Assessment of neurodegenerative disease progression
  • Monitoring treatment response in dementia
  • Quantitative analysis of amyloid PET scans
  • Quantitative analysis of tau PET scans
  • Research in neurodegenerative disorders

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Enterprise
DeploymentCloud
Mobile AppNone
Data Export Yes
Training Yes
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Nuclear Medicine, Radiology

Support & Reliability

Training Provided Yes

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2026-05-15K252563 510(k)Neurophet SCALE PET

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Neurophet SCALE PET

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Neurophet SCALE PET.

No videos found. Search YouTube directly

View all on YouTube

No FAQs available yet for this tool.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-19 | First Added: 2026-11-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.